Clearmind Medicine Reports Positive Retention Results for Intranasal Formulation of its Psychedelic-Based Neuroplastogen MEAI

Go back to Clearmind Medicine Reports Positive Retention Results for Intranasal Formulation of its Psychedelic-Based Neuroplastogen MEAI
(NASDAQ: CMND) Delayed: 1.07 +0.04 (3.88%)
Previous Close $1.03    52 Week High
Open $1.07    52 Week Low
Day High $1.11    P/E N/A 
Day Low $1.00    EPS
Volume 292,252